Best of Hematology and Breast Cancer™ 2026, Boise conference hero image

Best of Hematology and Breast Cancer™ 2026, Boise

Accreditation: 6.75 AMA PRA Category 1 Credit™ | 6.75 ABIM MOC II | 6.75 ACPE Pharmacy | 6.75 Nursing Contact Hours

Venue: The Grove Hotel, 245 South Capitol Boulevard, Boise, ID, United States

Start Date:
Register for Conference

Official conference page for Best of Hematology and Breast Cancer™ 2026, Boise.

About Best of Hematology and Breast Cancer™ 2026, Boise

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

50+

Faculty and committee

Our Speakers

Conference program and agenda

Our Agenda

Saturday, February 28th, 2026

All timings are in Mountain Time (MDT, GMT-06:00) time.

07:00 AM - 08:00 AMRegistration, Exhibits, & Breakfast
08:00 AM - 08:05 AMWelcome
08:05 AM - 08:20 AMBinaytara's Efforts in Improving Cancer Care Disparities - Bhawana Srivastava
08:20 AM - 09:20 AMSession 1: Updates in Classical Hematology

Session Chair: Andrew Scott Pierson, MD

08:20 AM - 08:40 AM

TTP/HUS Nicole Birrer, MD

08:40 AM - 09:00 AM

Modern Topics in Hemophilia Ming Y Lim, MBBCh

09:00 AM - 09:20 AM

Case-Based Panel Discussion, PNH Nicole Birrer, MD

09:20 AM - 10:20 AMSession 2: Acute Leukemia

Session Chair: Roland B. Walter, MD, PhD

09:20 AM - 09:35 AM

AML / MDS Roland B. Walter, MD, PhD

09:35 AM - 09:50 AM

ALL Ryan Cassaday, MD

09:50 AM - 10:20 AM

Case-Based Panel Discussion Rachel Davis

10:20 AM - 11:05 AMBreak & Exhibits - Product Theater sponsored by JNJ (non-CME accredited): Making the Case for Early Use of CAR-T Therapy in Multiple Myeloma - Karolina Faysman, NP, UCLA Health ROOM: Flichel
11:05 AM - 12:05 PMSession 3: Lymphoma

Session Chair: Travis Williams, DO

11:05 AM - 11:20 AM

B-Cell Lymphoma Travis Williams, DO

11:20 AM - 11:35 AM

CLL Stephen Spurgeon, MD

11:35 AM - 11:50 AM

Outpatient Bispecific Management Robert Mancini, PharmD

11:50 AM - 12:05 PM

Case-Based Panel Discussion, Practical Issues with Bispecifics Rachel Davis

12:05 PM - 12:50 PMSession 4: Multiple Myeloma

Session Chair: Leila Khaddour, MD

12:05 PM - 12:20 PM

Frontline Therapy of Multiple Myeloma Rebecca Silbermann, MD

12:20 PM - 12:35 PM

Relapsed/Recurrent Sequencing Multiple Myeloma Ghulam Rehman Mohyuddin, MD

12:35 PM - 12:50 PM

Case-Based Panel Discussion

12:50 PM - 01:50 PMLunch & Exhibits - Product Theater sponsored by Natera (non-CME accredited): From Signal to Strategy: How ctDNA testing with Signatera Is Changing Oncology Care - Dr. Angel Rodriguez, MD ROOM: Flichel
01:50 PM - 02:35 PMSession 5: Hematologic Malignancies

Session Chair: Clinton Roy Morgan

01:50 PM - 02:05 PM

MPN Bart L Scott, MD

02:05 PM - 02:20 PM

Use of Cell Therapy in Non-Malignant Conditions Daniel Couriel, MD, MBA

02:20 PM - 02:35 PM

Case-Based Panel Discussion Leila Khaddour, MD

02:35 PM - 03:50 PMSession 6: Metastatic Disease, Local Therapy & Survivorship

02:35 PM - 02:50 PM

What's Next After CDK4/6? ER+/HER2- Metastatic Breast Cancer Christos Vaklavas, MD

02:50 PM - 03:05 PM

Are we Finally Winning in Triple-Negative Breast Cancer? Namita Chittoria, MD

03:05 PM - 03:20 PM

Less May be More: De-escalation in HER2+ Disease Mei Wei, MD

03:20 PM - 03:35 PM

Beyond Survival: Fertility, Survivorship, & Managing Toxicities Roma Bhatia, MD

03:35 PM - 03:50 PM

New Kids on the Block: Antibody Drug Conjugates Christos Vaklavas, MD

03:50 PM - 04:05 PMBreak & Exhibits

Venue and map

Accreditations and continuing education

Acknowledgement of Commerical Support

This activity is supported with Independent Medical Education grants from:

  • Gilead
  • Stemline Therapeutics, Inc

Accreditation

Registration and pricing

Exhibitors and sponsorship